Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas

Details for Australian Patent Application No. 2010244136 (hide)

Owner Pronova BioPharma Norge AS

Inventors Hovland, Ragnar; Holmeide, Anne Kristin; Skjaeret, Tore; Braendvang, Morten

Agent Mallesons

Pub. Number AU-A-2010244136

PCT Pub. Number WO2010/128401

Priority 61/176,503 08.05.09 US

Filing date 7 May 2010

Wipo publication date 11 November 2010

International Classifications

C07C 57/03 (2006.01) Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms

A61K 31/19 (2006.01)

A61K 31/22 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07C 69/587 (2006.01) Esters of carboxylic acids

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/128401 Priority application(s): WO2010/128401

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010244142-Anti-IL-17F antibodies and methods of use thereof

2010244133-Antibodies against nerve growth factor (NGF) with enhanced in vivo stability